1. Home
  2. PTCT vs OSIS Comparison

PTCT vs OSIS Comparison

Compare PTCT & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • OSIS
  • Stock Information
  • Founded
  • PTCT 1998
  • OSIS 1987
  • Country
  • PTCT United States
  • OSIS United States
  • Employees
  • PTCT N/A
  • OSIS N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • OSIS Industrial Machinery/Components
  • Sector
  • PTCT Health Care
  • OSIS Technology
  • Exchange
  • PTCT Nasdaq
  • OSIS Nasdaq
  • Market Cap
  • PTCT 5.3B
  • OSIS 4.2B
  • IPO Year
  • PTCT 2013
  • OSIS 1997
  • Fundamental
  • Price
  • PTCT $71.58
  • OSIS $284.94
  • Analyst Decision
  • PTCT Buy
  • OSIS Strong Buy
  • Analyst Count
  • PTCT 17
  • OSIS 6
  • Target Price
  • PTCT $73.24
  • OSIS $260.83
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • OSIS 168.6K
  • Earning Date
  • PTCT 11-04-2025
  • OSIS 10-30-2025
  • Dividend Yield
  • PTCT N/A
  • OSIS N/A
  • EPS Growth
  • PTCT N/A
  • OSIS 14.72
  • EPS
  • PTCT 8.94
  • OSIS 8.81
  • Revenue
  • PTCT $1,779,150,000.00
  • OSIS $1,753,782,000.00
  • Revenue This Year
  • PTCT $119.02
  • OSIS $8.98
  • Revenue Next Year
  • PTCT N/A
  • OSIS $5.46
  • P/E Ratio
  • PTCT $8.03
  • OSIS $32.32
  • Revenue Growth
  • PTCT 97.54
  • OSIS 9.37
  • 52 Week Low
  • PTCT $35.95
  • OSIS $146.32
  • 52 Week High
  • PTCT $73.98
  • OSIS $288.64
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 71.08
  • OSIS 69.42
  • Support Level
  • PTCT $66.10
  • OSIS $271.47
  • Resistance Level
  • PTCT $73.98
  • OSIS $256.78
  • Average True Range (ATR)
  • PTCT 2.58
  • OSIS 10.68
  • MACD
  • PTCT 0.10
  • OSIS 3.15
  • Stochastic Oscillator
  • PTCT 70.62
  • OSIS 92.82

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.

Share on Social Networks: